<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20051210/bs_nm/merck_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/nm/20051211/2005_12_10t141048_450x312_us_merck.jpg?x=130&y =90&sig=4JMrkveF2ZpicLEs6tDigQ--" align="left" height="90" width="130" alt="File photo shows a New York City pharmacist holding bottles of the prescription arthritis and pain medication VIOXX September 30, 2004. A U.S. judge asked the jury in the first federal lawsuit against Merck and Co's Vioxx to keep deliberating on Saturday after the panel said it could not reach a verdict on whether the drug contributed to the death of a Florida man. (Mike Segar/Reuters)" border="0" /></a>Reuters - Jurors in the first federal lawsuit
against Merck & Co's painkiller Vioxx adjourned on Saturday and
will return on Monday to try to reach a verdict despite telling
the judge earlier in the day they were deadlocked.</p><br clear=all>
View the entire article:
Vioxx jury to resume deliberations Monday (Reuters)